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ABSTRACT
Objectives The objective of this work was to apply the
two-stage clonal expansion model, with the intention to
expand the literature on epidemiological applications of
the model and demonstrate the feasibility of
incorporating biologically based modelling methods into
the widely used retrospective cohort study.
Methods The authors fitted the two-stage clonal
expansion model model to three occupational cohort
studies: (1) a cohort of textile workers exposed to
asbestos and followed for lung cancer mortality; (2)
a cohort of diatomaceous earth workers exposed to silica
and also followed for lung cancer mortality; and (3)
a cohort of automotive manufacturing workers exposed
to straight metalworking fluid (MWF) and followed for
larynx cancer incidence. The model allowed the authors
to estimate exposure effects in three stages: cancer
initiation (early effects), promotion or malignant
transformation (late effects).
Results In the first cohort, the authors found strong
evidence for an early effect of asbestos on lung cancer
risk. Findings from analyses of the second cohort
suggested early and less evidently late effects of silica
on lung cancer risk. In the MWF (third) cohort, there was
only weak evidence of straight MWF exposure effects on
both early and late stages. The authors also observed
a late birth cohort effect on larynx cancer risk.
Conclusions The findings for asbestos and silica were
essentially confirmatory, supporting evidence for their
early effects on lung cancer from a large body of literature.
The effect of straightMWF on larynx cancer was less clear.
INTRODUCTION
Perhaps the most successful biologically based
models in epidemiology are the multistage and
two-stage carcinogenesis models ﬁrst proposed
by Armitage and Doll,1 and Moolgavkar and
Knudson,2 3 respectively. The latter model, and
subsequent variants, have been applied to both
animal and human cancer data,3e14 but in only
a limited number of cases has such a model been
applied in studies containing quantitative exposure
data on individuals.8 10 13e15 The two-stage model
allows one to compare the strength and goodness of
ﬁt of the association between exposure and cancer
risk, alternately assuming that the exposure acts at
an early or a late stage in carcinogenesis. Stage
information is potentially useful for understanding
human risk, and for making predictions about the
time trends of environmental cancers.
The two-stage clonal expansion (TSCE) model
(also known as the Moolgavkar or Moolgavkare
Knudson two-stage model of carcinogenesis)
formalises carcinogenesis as a three-phase process.
In the ﬁrst phase (initiation), a susceptible stem cell
undergoes one or more events which transform this
normal cell into an intermediate stage. This may be
one or more mutations, but epigenetic changes
could also be involved with no loss of relevance of
the model form. In a second phase, the initiated cell
may undergo clonal expansion, also called promo-
tion. If there is clonal expansion of intermediate
cells, then the probability is increased that, in
a ﬁnal phase (progression), one of the clones of
initiated cells will undergo an additional genetic
change leading to full malignant transformation
and subsequently to clinically detectable cancer.
This ﬁnal event is called malignant conversion. The
two rare events (initiation and malignant conver-
sion) are the ‘stages’ of the TSCE, but the growth
of a clone of intermediate cells is also recognised as
a critical phase during which environmental
chemicals and cancer-prevention interventions can
act; hence, the choice of the name TSCE rather
than simply a two-stage model.
There is good experimental and clinical evidence
that many human cancers pass through these three
phases, and there is also a small but growing body
of epidemiological evidence consistent with the
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What this paper adds
< The most successful biologically based models
in epidemiology, the multistage and two-stage
carcinogenesis models first proposed by
Armitage and Doll and Moolgavkar and
Knudson respectively, have been applied to
only a limited number of studies with individual
quantitative exposure data.
< The present study was an epidemiological
application of the two-stage clonal expansion
(TSCE) Moolgavkar and Knudson model in three
occupational cohorts.
< The findings strengthened previous studies on
the relationships between lung cancer and
asbestos and silica exposures by providing
maximum likelihood evidence on the stage of
action of these carcinogens. This application
also demonstrates the feasibility of incorpo-
rating biologically based modelling methods into
the widely used cohort study to provide
evidence on the stage of action of occupational
and environmental carcinogens.
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hypothesis that environmental carcinogens act on one or more
of these phases.8 10 13 14 16 17 The TSCE model is the simplest
stochastic mathematical model of the initiation, promotion and
malignant conversion paradigm of carcinogenesis.18
Despite its theoretical and mathematical development, the
TSCE has not been applied to more than a handful of occupa-
tional cohort studies. Our objective in this paper was to apply
the method to three existing datasets in order to expand
the literature on epidemiological applications of the model.
This research project had the long-term goal of aiding cancer-
prevention efforts by demonstrating the feasibility of incorpo-
rating biologically based modelling methods into the widely
used retrospective cohort study.
The TSCE was used to study exposureecancer risk associa-
tions in: (1) a cohort of textile workers exposed to asbestos and
followed for lung cancer mortality; (2) a cohort of diatomaceous
earth workers exposed to silica and also followed for lung cancer
mortality; and (3) a cohort of automotive manufacturing
workers exposed to straight metalworking ﬂuid (MWF) and
followed for larynx cancer incidence. Quantitative individual
lifetime exposure data were available for all three cohorts, so
that the model could make use of both inter- and intraindividual
variations in exposure intensity. Asbestos and silica are well-
recognised lung carcinogens, and the particular datasets
employed here have been previously analysed by standard
methods and the results published by others.19e21 In contrast,
the association between straight MWF and larynx cancer has
only been reported in a single occupational cohort,22 and it was
these same data that we have reanalysed in this paper.
METHODS
Form of the TSCE model
The two-stage clonal expansion model can be schematised as
shown in ﬁgure 1. In this model, four time-dependent parame-
ters describe the stochastic process of carcinogenesis, starting
from the pool of normal cells to the occurrence of the ﬁrst
malignant cell, and are: a1(s) the ﬁrst mutation rate leading to
the creation of an initiated or premalignant cell, b(s) and d(s) the
birth and death rates of premalignant cells, and a2(s) the second
mutation rate leading to the creation of a malignant cell.
The model assumes that a number of normal susceptible cells
are initiated at time s, therefore becoming premalignant, by
a non-homogenous Poisson process with intensity a1(s)3X(s);
where X(s) is the expected number of normal cells (assuming X
is a ﬁxed number), and a1(s) is the rate of initiation (or the ﬁrst
mutation rate) at time s. At any given time (s), the premalignant
(initiated) cells can divide into two premalignant cells with birth
rate b(s), die with death rate d(s) or divide asymmetrically into
one initiated cell and one malignant cell with rate a2(s).18 More
detailed descriptions of this model are given in earlier work by
Heidenreich and colleagues18 23 and in more recent applications
of the model.24 25
According to this model, exposure to a carcinogen could act in
one of several ways: by increasing the transition or mutation rate
from normal to intermediate cells (increasing a1); increasing the
transition rate from intermediate to malignant cells (increasing
a2); or increasing the proliferation of intermediate cells by
altering either the birth (b) or death rate (d) of these cells. By
studying the time course of exposure and its relationship to risk
in an exposed population, it may be possible to determine which
of these modes of action is occurring. Also, different carcinogenic
exposures that occur in the same environment may act via
different pathways, and these pathways may be distinguishable
mathematically. In this model, a tumour initiator is postulated
to act by increasing a1, an early acting exposure agent, while
a promoter should act by increasing the proliferation of inter-
mediate stage cells through altering the balance of (bed) so as to
increase the pool of intermediate cells ready to receive the second
‘hit’ (a2), or a late acting exposure.4 14
Datasets
Asbestos and lung cancer
The cohort includes all workers employed in asbestos textile
operations in a factory in South Carolina for at least 1 month
between 1 January 1940 and 31 December 1965, and followed
for vital status through 31 December 1990 (table 1).20 There
were a total of 116 000 person years of observation and 1259
deaths. Of these, there were a total of 124 deaths from lung
cancer. Final models (males only) included 74 lung cancer deaths.
A detailed exposure reconstruction allowed Dement and
colleagues to assign annual exposure estimates to each worker.20
Several authors have published analyses of these data, and all
show strong associations between cumulative asbestos exposure
and lung cancer risk.19 20 Models with continuous exposure
variables showed risk of lung cancer primarily associated with
exposures occurring 20e24 years prior diagnosis (RR¼4.6, 95%
CI 1.3 to 16.3), and less evidently for exposures in the
15e20 years (RR¼1.4; 95% CI 0.4 to 4.8).26
Silica and lung cancer
The Diatomaceous Earth (DE) cohort included 2342 white males
(23% Hispanic) who were employed for at least 12 months
including at least 1 day between 1 January 1942 and 31
December 1987 in the diatomaceous earth mining and
processing industry.21 27 Vital status was determined for 91% of
the cohort, and cause of death was ascertained for 716 of 749
(96%) of identiﬁed deaths. Cumulative exposure estimates to
respirable dust and respirable crystalline silica have been
computed based on historical reconstruction of exposures for all
subjects.27 In the early study of this cohort, excess mortality
based on 77 lung cancer deaths was found in association with
cumulative crystalline silica equal or greater than 5 mg/m3-years
(RR¼2.11, 95% CI 1.07 to 4.11, no exposure lag). 21
Metalworking fluids and larynx cancer
Three automotive parts manufacturing facilities in Michigan
were studied.28 All hourly employees who had worked at least
3 years prior to 1 January 1985 were eligible for inclusion in the
study. Hire dates ranged from 1917 to 1981, and a total of 46 384
employees met the study deﬁnition, of whom approximately
10% were female, and 21% AfricaneAmerican. By the end of
initial follow-up in 1984, 10 159 (22%) had died. The cause of
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Figure 1 Two-stage clonal expansion model.
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death was ascertained for 92% of these subjects, based on death
certiﬁcates. Past exposures to MWF and certain components
were estimated based on air sampling measurements, review of
plant records and interviews with personnel.29
This analysis included 78 incident cases of laryngeal cancer in
the cohort, and 3093 subcohort members, males only.22 A posi-
tive association was found for cumulative exposure to straight
MWF more than 10 years before risk age and larynx cancer risk
(RR¼1.08, 95% CI 1.03 to 1.14, for each 5 mg/m3-years).22
Fitting the TSCE model
To implement this model, we used software developed by
Heidenreich, Luebeck and Moolgavkar.18 Heidenreich and
colleagues, and Hanin and Yakovlev30 have found that there is
a fundamental identiﬁability problem in the TSCE model which
prohibits the estimation of the values of the fundamental model
parameters directly from incidence or mortality data alone: the
ﬁrst and second mutation rates (a1 and a2); and the birth and
death rates of intermediate cells (b and d). Hence, the parameter
combinations A, B and C are estimated instead as functions of
the four fundamental parameters, and also used in our version of
the software.
The two sets of parameters can be related by the following
approximations:
Ayb d Bya2 C ¼ a1X=b
where b, d, a1, a2 and X were deﬁned above. These approxi-
mations indicate that A is the negative of the net proliferation
rate of intermediate cells. Parameter B is approximately
a2/(1d/b), which may also be referred to an ‘effective’ malig-
nant transformation rate, assuming d is negligible (if there is
non-extinction of the intermediate cell clone). C is a function of
the ﬁrst mutation rate (a1), birth rate of intermediate cells (b)
and size of the normal cell pool (X). Because the latter is
assumed to be large and essentially unchanging in size (the levels
of exposure to carcinogens in a modern workplace are unlikely to
be so high as to be directly cytotoxic, and the ﬁrst mutation
rates are likely to be so small that they will not deplete the pool
of normal cells to any appreciable degree), C can be seen as
a ratio of the ﬁrst mutation rate to the birth rate of intermediate
cells. That is, it represents the balance of these two pathways for
the growth of the intermediate cell pool.
Fitting the model to epidemiological data
Exposure was treated as a continuous lifetime cumulative
exposure variable and allowed to modify the baseline parameters
of the model. The model parameters are time-dependent and
were estimated as a function of exposure changing overtime
(annually). The model was ﬁtted in terms of parameters A, B
and C, as noted above. Following the work of Heidenreich and
colleagues,18 we systematically evaluated ﬁve functional forms
by which exposure was allowed to modify one or more of the
three parameters. The following exposure functions were used
(P represents one of the three parameters A, B or C):
Linear : P¼P13ð1 þ P23EÞ
Power : P¼P131 þ P23EP3
Log : P¼P13ð1 þ lnð1 þ P23EÞÞ
Exponential : P¼P13eP23E
Negative exponential : P¼P13eP23E
where P1 is a baseline parameter, and P2 and P3 are additional
parameters representing the unit change in P as a function of
exposure (E). We ﬁtted the model in the following way. First, the
model was ﬁtted to the cancer data in the cohort with no
provision for exposure affecting any of the parameters of the
model (baseline model). This yielded baseline estimates of the
three unknown parameters. Then, cumulative exposure (E)
effects on each of the parameters were allowed, investigating the
ﬁve functional forms.
We also allowed year of birth (birth cohort, or BC) to affect
model parameters. Moolgavkar and colleagues have found that
for lung cancer, there is a strong birth cohort effect, which they
interpret as primarily an effect of changing smoking prevalence
over the second half of the 20th century. We subtracted the
earliest birth year in the cohort from all others, so that the term
was always positive. We investigated linear and exponential
effects of birth cohort on all three parameters. Finally, we
combined exposure and birth cohort effects in the same model.
Maximum likelihood methods are used to ﬁnd the most likely
values of the parameters. The ﬁts of alternative models can be
compared using the 2 log likelihood statistics (2LL). Differ-
ences in 2LL are expected to have a c2 distribution. When two
competing models are nested one within the other, one can test
the null hypothesis of no improvement in ﬁt by the larger model
compared with the smaller using the difference in 2LL, with
degrees of freedom equal to the number of additional parameters
in the larger model. One can also examine 95% CIs for the
estimated coefﬁcients, to evaluate the strength of the evidence
for an exposure (or birth cohort) effect on a model parameter.
We did not perform formal hypothesis testing, as it was not
appropriate for this methods development research. However, p
values do provide a way to judge of what is a ‘large’ improve-
ment in goodness of ﬁt for an exposure model, compared with
a baseline model. We used the following criteria for the weight of
evidence indicated by a reduction in 2LL (the table below
assumes one degree of freedom difference between the exposure
and baseline models):
Weight of evidence Reduction in L2 LL Associated p value
Weak 3.8e2.1 0.05e0.15
Modest 6.6e3.8 0.01e0.05
Strong >6.6 <0.01
Table 1 Description of datasets of the three occupational cohorts
Asbestosdlung cancer Silicadlung cancer
‘Straight’ (petroleum-based)
metalworking fluiddlarynx cancer
References Dement et al20 Checkoway et al21; Seixas et al27 Zeka et al22
Definition of cohort 1247 white males employed
between 1940 and 1965
2342 white males employed at least 1 year
between 1942 and 1987
46 000 workers employed at least 3 years
between 1938 and 1985
Period of follow-up 1940 to 1990 1942 to 1994 1941 to 1994; analyses only for males
Case definition Mortality Mortality Incidence
No of cases 74 77 78
Mean (range) age of death/
diagnosis (years) of cases
64.0 (46.5 to 88.6) 63.4 (44.0 to 79.0) 63.2 (39.2 to 81.2)
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RESULTS
Overview
A large number of different models were ﬁtted to the data from
each of the three cohorts. Not all models converged, and this
was interpreted as meaning that the model that was being
estimated did not ﬁt the observed data well. In the detailed
results presented below, only the best-ﬁtting parameterisation
for the effect of exposure, birth cohort or the combined effects
(exposure and birth cohort) on one of the three parameters A, B
or C is shown.
Asbestos and lung cancer
The baseline model produced reasonably precise estimates of
parameters A and C with 95% CIs of less than an order of
magnitude (table 2). Parameter B, equivalent to the second
mutation rate (a2), was estimated to be very smalldabout 106,
and imprecisely estimatedd95% CI of about three orders of
magnitude. The 2LL for the baseline model was 937.1. Models
in which one of the parameters was allowed to vary with birth
cohort either did not converge (parameter B) or had only very
slightly better ﬁts than the baseline model (parameters A and C).
When models were ﬁtted in which exposure was allowed to
modify one of the three parameters, convergence was achieved
only when exposure was modifying C. All ﬁve parameterisations
of the exposure effect on C ﬁtted better than the baseline model.
The log exposure model had the smallest values of 2LL, 928.1.
With one degree of freedom difference from the baseline model,
this reduction in 2LL of 9.0 was substantial.
Models in which exposure was allowed to modify either A,
the net proliferation rate of intermediate cells, or B, the second
mutation rate ﬁtted poorly.
The best-ﬁtting model in which exposure modiﬁed parameter
C had this form:
C¼0:0183ð1 þ lnð1 þ 1:63EÞÞ
The 95% CI for the ﬁrst coefﬁcient of the above equation
was (0.0059 to 0.058), and for the second coefﬁcient it was
(0.065 to 39).
Silica and lung cancer
The baseline model, in which neither exposure nor birth cohort
was allowed to inﬂuence model parameters was qualitatively
similar to the baseline model for the asbestos data (table 3).
Again, parameters A and C were estimated with fair precision, as
evidenced by their 95% CIs, while parameter B was smaller and
less precisely estimated. The baseline model had a goodness of ﬁt
(2LL) of 1048.0. As in the asbestos data, adding birth cohort
alone to the baseline model did not improve the ﬁt. For this
reason, we did not attempt to ﬁt models combining exposure
and birth cohort effects.
Models were ﬁtted in which exposure was allowed to affect
parameters A or C. In none of these models was the improve-
ment in ﬁt compared with the baseline model as impressive as it
was in the asbestos dataset. The best ﬁtting model was the
linear form of an exposure effect on parameter C, with 2LL
value of 1045.9 (table 3). This model had a reduction in 2LL of
about 2 and can be expressed as follows:
Table 2 Results of fitting a two-stage clonal expansion model to the study of lung cancer and exposure
to asbestos (Dement et al20)
Model Parameter A Parameter B Parameter C L2log likelihood
Baseline 0.24 (0.15 to 0.32)* 0.17e6 (0.34e8 to 0.82e5) 0.041 (0.020 to 0.083) 937.1
Birth cohort affectingy
A 0.123(1+BC0.14e8) 0.17e6 0.41e1 936.8
B e e e x
C 0.24 0.17e6 0.19e13(1+BC0.33e1) 936.9
Exposure affectingz
A e e e x
B e e e x
C 0.24 0.18e6 0.0183(1+ln(1+1.6*E)) 928.1
Parameter Aybd is the negative of the net proliferation rate of intermediate cells. Parameter Bya2 is approximately the
malignant transformation rate. Parameter C¼a13X/b is the rate of growth of the intermediate cell pool.
*95% CIs shown for baseline model. See text for 95% intervals for final models.
yBirth cohort (BC) affecting one parameter at one time, while the other two parameters remain unchanged.
zExposure (E) affecting one parameter at one time, while the other two parameters remain unchanged.
xPoor fitdmodels did not converge.
Table 3 Results of fitting a two-stage clonal expansion model to a study of lung cancer and exposure to
crystalline silica (Checkoway et al21)
Model Parameter A Parameter B Parameter C L2log likelihood
Baseline 0.26 (0.37 to 0.14)* 0.78e7 (0.41e9 to 0.15e4) 0.20e1 (0.94e2 to 0.44e1) 1048.0
Birth cohort affecting:y
A 0.263(1+0.43e83BC) 0.79e7 0.20e1 1048.0
B 0.26 0.79e73e0.41e73BC 0.20e1 1048.0
C 0.26 0.79e7 0.20e13e0.50e103BC 1048.0
Exposure affecting:z
A 0.253(1+(1e0.373E)) 0.11e6 0.22e1 1046.8
B 0.26 0.78e73(1+0.95e93E) 0.20e1 1048.0
C 0.26 0.78e7 0.19e13(1+3.43E) 1045.9
Parameter Aybed is the negative of the net proliferation rate of intermediate cells. Parameter Bya2 is approximately the
malignant transformation rate. Parameter C¼a13X/b is the rate of growth of the intermediate cell pool.
*95% CIs shown for baseline model. See text for 95% intervals for final models.
yBirth cohort (BC) affecting one parameter at one time, while the other two parameters remain unchanged.
zExposure (E) affecting one parameter at one time, while the other two parameters remain unchanged.
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C¼0:0193ð1 þ 3:403EÞ
The 95% CIs of the two coefﬁcients were: (0.009 to 0.039) and
(0.50 to 25), respectively.
Models in which exposure modiﬁed parameter A ﬁtted
slightly less well. Similar to the case of asbestos, the results for
silica suggest that exposure may act at an early stage in carci-
nogenesis, however, with also a suggestion for a late stage effect
(promotion).
Metalworking fluids and larynx cancer
The baseline model, in which neither exposure nor birth cohort
was allowed to inﬂuence model parameters, was again qualita-
tively similar to those for asbestos and silica. Parameters A and C
were estimated with fair precision, while parameter B was much
smaller and less precisely estimated.
Unlike in the other two datasets, we found strong evidence for
a birth cohort effect in these data (table 4). Large improvements
in the 2LL were consistently observed when birth cohort was
allowed to affect parameter A. The best ﬁt was observed for the
simple power function of birth cohort affecting A. A represents
the net proliferation rate of intermediate cells, and the birth
cohort effect we found could be interpreted to indicate a late
stage effect. Birth cohort effects were also found on parameters B
and C, although the model ﬁts were not as good as those for
models allowing effects on parameter A.
For investigation of exposure effects, we deﬁned a new
‘baseline’ model which included an effect of birth cohort on
parameter A, and compared all exposure models to this one.
Models in which exposure was allowed to modify any of the
three parameters showed only very modest improvements in ﬁt
over the baseline model. No evidence of an effect on parameter B
was observed. Nearly identical ﬁts were found with models that
allowed an exposure effect on A or C, but the largest reduction
in 2LL was only about 2. The best ﬁtting model had a linear
effect of exposure on parameter A:
A¼0:0493ð1 þ BC0:4731 þ 0:079E
The 95% CIs for these three coefﬁcients were: (0.068 to
0.029), (0.40 to 0.54) and (0.016 to 0.40) respectively.
Because of the observation of both birth cohort and exposure
effects, we investigated a variety of different model forms
including both of these effects. We allowed birth cohort to affect
A and C simultaneously with the best functional forms (results
not shown), while exposure remained on either A or C at its best
functional form. Also, exposure was allowed to affect A and C
simultaneously, while birth cohort remained on A in its best
functional form. Either there were no improvements in the
model ﬁt, or the ﬁts deteriorated. We also examined if there was
collinearity of birth cohort and exposure, when these two vari-
ables were used together in the models. Results suggested no
important collinearity between birth cohort and exposure.
DISCUSSION
Biologically based cancer models
Occupational and environmental epidemiology and associated
risk assessment research rely heavily on quantitative models to
accurately assess the strength of exposureedisease associations.
Most quantitative exposureeresponse models are largely
empirical in structure, incorporating only a limited number of
generic assumptions, such as the multiplicative relation between
covariates included in common RR regression models. These
modelsdlogistic and Poisson regression, and the Cox model, for
exampledare ﬂexible and seem to ﬁt a variety of data sets
reasonably well. Unfortunately, no direct validation is ever really
possible, and so doubts remain about the accuracy of risk
predictions from these models.31e33 An additional challenge to
the application of these models is that when the results of an
incorrectly speciﬁed model are applied to a population with
different distributions of exposure and other covariates than
those in the study population, the risk predictions may be
biased. This will be true, even if the model ﬁts the data
adequately. This creates another reason for caution in the
interpretation of the results of standard empirical modelling
methods.
Biologically based models may help to improve the accuracy
of exposure-risk estimation in several ways.2 34e37 A biologically
based epidemiological model derives its structure, and possibly
some of its parameters, from experimental studies and theoret-
ical models of the pathophysiological mechanisms underlying
the disease processes being studied. There are only a limited
number of examples of the use of such models, partly because of
their complexity, and partly because of the normal skepticism of
researchers to adopt unproven methods. However, agreement
between a biologically based model and empirical models
ﬁtted to the same data lends validity to both. In addition, the
biological model tends to have parameters which are
Table 4 Results of fitting a two-stage clonal expansion model to a study of larynx cancer and exposure
to straight metalworking fluid (Zeka et al22)
Model Parameter A Parameter B Parameter C
L2log
likelihood
Baseline0.20 (0.27 to 0.12)* 0.21e5 (0.83e7 to 0.51e4) 0.15e1 (0.78e2 to 0.29e1) 1156.1
Birth cohort affecting:y
A 0.51e13(1+BC0.46) 0.11e8 0.16e1 1094.3
B 0.40 0.21e143e(0.253BC) 0.10e1 1105.2
C 0.20 0.20e6 0.69e63(1+BC0.33e+1) 1103.8
Exposure affecting:z
A 0.49e13(1+BC0.47)3(1+0.0793E) 0.18e8 0.18e1 1092.0
B e e e x
C 0.51e13(1+BC0.46) 0.14e8 0.16e13e(0.723E) 1092.9
Parameter Aybd is the negative of the net proliferation rate of intermediate cells. Parameter Bya2 is approximately the
malignant transformation rate. Parameter C¼a13X/b is the rate of growth of the intermediate cell pool.
*95% CIs shown for baseline model. See text for 95% intervals for final models.
yBirth cohort (BC) affecting one parameter at one time, while the other two parameters remain unchanged.
zExposure (E) affecting one parameter at one time, while the other two parameters remain unchanged. BC affecting parameter A
simultaneously.
xPoor fitdmodels did not converge.
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interpretable as aspects of physiological processes, lending
plausibility to study results.
Experimental evidence now makes it clear that for most types
of cancer, there are more than two irreversible steps in the
process of complete cell transformation.38 39 Furthermore, if the
number of steps or stages is variable, meaning that there are
numerous pathways from an initial carcinogenic exposure to
tumour initiation, the very concept of a model based on discrete
stages may be incorrect. Despite this complexity, there may be
public health utility in the distinction between agents that act
early in the carcinogenic process (initiators) and those that act
late (promoters). More detailed subdivision of the process, even
if it were possible to achieve with epidemiological data, may not
have much public health relevance (eg, determining whether an
agent acts at the ﬁfth or sixth of eight stages). For these reasons,
a two-stage model may be quite useful, even when the true
process is much more complex. In particular, late-stage carcin-
ogens (promoters) have been poorly studied in epidemiology,
partly because of the strong tendency to assume that lag periods
of a decade or more are the rule in cancer epidemiology. Thus,
a model that explicitly investigates the early/late distinction
could be a useful addition to the epidemiologist’s standard
repertoire.
Both asbestos and silica appear to act early in the process of
lung carcinogenesis. MWF had a less clear effect, but there was
some evidence for a later stage of action on larynx cancer. The
investigations of asbestos and silica were, in a sense, tests of
‘positive controls’dcompounds for which we have strong
evidence that they act as cancer initiators. Thus, our results are
reassuring evidence that the method is capable of ﬁnding these
expected effects.
Asbestos is perhaps the best-known example of a human
cancer initiator. In a previous reanalysis of the same data used
here, Pearce calculated cumulative exposure in 5-year time
windows, and found that the risk of lung cancer was strongly
associated with exposures occurring 20e24 years before lung
cancer death, with little or no risk associated with exposures at
any other time (table 10.9).26 In the present analyses, the
evidence for an early effect of asbestos was strong, and there was
no evidence for a late-stage effect.
Silica has also been found to increase lung cancer risk
after a long latency in standard published epidemiological
models.21 40e42 We interpret our ﬁndings with the two-stage
model to be consistent with this observation of an early effect of
exposure on risk. The evidence was not strong, however, and
models with a late-stage effect ﬁtted only slightly worse.
Metalworking ﬂuid has been found to increase larynx cancer
in a single large cohort study.22 Our TSCE model application in
the same dataset found an important late-stage birth cohort
effect. Moolgavkar and colleagues suggested that controlling for
birth cohort might adjust for time trends in lifestyle risk factors,
such as smoking and drinking. Tobacco smoking is thought to
have both initiating and promoting effects on laryngeal cancer,
while alcohol probably serves as a promoter.43e46 The study by
Moolgavkar on lung cancer risk among coke oven workers also
found that birth cohort affected the net-proliferation rate of
intermediate cells, a later effect.13 In contrast, studies by
Luebeck among Colorado uranium miners14 and of Hazelton in
a large cohort of Chinese tin miners16 both suggested an effect of
birth cohort on lung cancer initiation. Thus, the role of birth
cohort in the two-stage model probably represents more than
simply the time trends in smoking and drinking prevalence.
The weak evidence of MWF exposure effects on both early
and late stages might be interpreted as essentially a negative
ﬁnding. Overall, the more modest ﬁts for MWF and larynx
cancer than for either lung carcinogen are consistent with the
results of standard analyses.22
Smoking information, the main risk factor for both cancer
types, lung and laryngeal cancer, was not available for all three
cohorts. Lack of information on non-occupational exposures,
including smoking, is a common issue in retrospective occupa-
tional cohort studies. Because this is an important issue for
epidemiological investigation and health policy making, we have
previously shown that smoking (or drinking in the case of
larynx cancer), even in the more extreme confounding scenarios,
is unlikely to increase or decrease the relative risks associated
with exposure by more than 20%.47 The confounding effect, if
present, would be of more concern in the case of small to
medium relative risks, as may be the case of the association for
larynx cancer and MWF. However, such an effect would likely
have less impact on strong associations, such as those between
asbestos and silica and lung cancer.
CONCLUSIONS
Application of the TSCE model to three occupational cohort
studies found evidence that both asbestos and silica appear to
act early in the process of lung carcinogenesis. The effect of
straight MWF on larynx cancer was less clear, but there was
some evidence for a later stage of action. The ﬁndings for
asbestos and silica are essentially conﬁrmatory, as the evidence
for their early effects on lung cancer from a large body of literature
is quite strong.
The TSCE model is a different approach to epidemiological
modelling from that provided by standard methods like logistic
or Poisson regression or the Cox proportional hazards model. It
allows formal investigation of competing hypotheses about
whether a chemical acts at early or late stages of carcinogenesis.
Recent papers by Richardson48 also show promising alternatives
to ﬁtting the TSCE model using SAS software. We hope that
these examples will encourage researchers to ﬁt biologically
based models in their epidemiological datasets.
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